Compare MLTX & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLTX | UWMC |
|---|---|---|
| Founded | 2021 | 1986 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | MLTX | UWMC |
|---|---|---|
| Price | $15.69 | $4.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $22.22 | $6.63 |
| AVG Volume (30 Days) | 2.3M | ★ 21.5M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | N/A | ★ 8.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $2,703,097,000.00 |
| Revenue This Year | N/A | $17.46 |
| Revenue Next Year | N/A | $22.16 |
| P/E Ratio | ★ N/A | $81.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.95 | $3.80 |
| 52 Week High | $62.75 | $7.14 |
| Indicator | MLTX | UWMC |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | 35.21 |
| Support Level | $14.47 | $4.88 |
| Resistance Level | $16.69 | $5.26 |
| Average True Range (ATR) | 0.88 | 0.33 |
| MACD | -0.17 | -0.12 |
| Stochastic Oscillator | 49.79 | 7.17 |
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
UWM Holdings Corp engages in the origination, sale, and servicing of residential mortgage loans in the wholesale channel. The company provides independent mortgage advisors across the states and the district of Columbia.